A drug under the name of Zantac 360, which does not contain the alleged cancer-causing ingredient ranitidine, is still being sold currently. GSK’s collaboration with Cambridge University comes after ...

Circle to Search is coming to compatible phones with OxygenOS 15 The update also adds new boot animation, icons, and shelf card choices OxygenOS 15 introduces Gemini-powered AI Notes ...

Digging into the Capital One 360 Performance Savings account Having a safe place for storing your money is key to giving you peace of mind. Now is as great a time as ever to secure a reasonable ...

The unique 360-degree view feature on CarDekho lets you explore Tata Nexon from each and every angle on your mobile device. Take a detailed tour of Tata Nexon’s exterior and interior without ...

How do you explain one Zantac manufacturer kiboshing a favorable trend of defense verdicts and decisions – with a massive $2.2 billion settlement? The answer appears to lie with the whistleblower suit ...

If you or a loved one took Zantac (ranitidine) and later developed health complications, particularly cancer, you may be entitled to legal compensation through a Zantac lawsuit. Due to increasing ...

When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. Unfortunately, there aren't many details available in the FCC listing. The filing only went ...

The Torras Ostand 360° Spin Fusion MagSafe Case is a solid case for the iPhone 16, 16 Pro, and 16 Pro Max with a unique twist. The metal ring on the back serves as a magnet to align the case ...

Simply sign up to the Investment Banking myFT Digest -- delivered directly to your inbox. As year-end approaches, investment banks embark on one of their most hallowed (and often groaned-about ...

GSK agreed to pay $2.2 billion to settle approximately 80,000 lawsuits in U.S. courts over claims its heartburn drug, Zantac, caused cancer. The settlements account for 93% of all cases and were ...

The UK based drug firm GSK has agreed to pay up to $2.2bn (£1.7bn; €2bn) to settle claims that the heartburn drug ranitidine (previously marketed in the US as Zantac) caused cancer. The deal, ...

GSK has struck a $2.2 billion agreement to settle the vast majority of U.S. lawsuits filed against it over claims its Zantac heartburn remedy causes cancer. The British drugmaker’s settlement ...